NO20064315L - T1 MRI traceable drug delivery particles and use thereof - Google Patents

T1 MRI traceable drug delivery particles and use thereof

Info

Publication number
NO20064315L
NO20064315L NO20064315A NO20064315A NO20064315L NO 20064315 L NO20064315 L NO 20064315L NO 20064315 A NO20064315 A NO 20064315A NO 20064315 A NO20064315 A NO 20064315A NO 20064315 L NO20064315 L NO 20064315L
Authority
NO
Norway
Prior art keywords
drug delivery
traceable
mri
delivery particles
drug
Prior art date
Application number
NO20064315A
Other languages
Norwegian (no)
Inventor
Esben A Nilssen
Sigrid Fossheim
Original Assignee
Epitarget As
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Epitarget As filed Critical Epitarget As
Priority to NO20064315A priority Critical patent/NO20064315L/en
Priority to PCT/NO2007/000334 priority patent/WO2008035985A2/en
Priority to EP07808630A priority patent/EP2066357A2/en
Priority to US12/441,116 priority patent/US20100158817A1/en
Publication of NO20064315L publication Critical patent/NO20064315L/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K49/00—Preparations for testing in vivo
    • A61K49/06—Nuclear magnetic resonance [NMR] contrast preparations; Magnetic resonance imaging [MRI] contrast preparations
    • A61K49/18—Nuclear magnetic resonance [NMR] contrast preparations; Magnetic resonance imaging [MRI] contrast preparations characterised by a special physical form, e.g. emulsions, microcapsules, liposomes
    • A61K49/1806—Suspensions, emulsions, colloids, dispersions
    • A61K49/1812—Suspensions, emulsions, colloids, dispersions liposomes, polymersomes, e.g. immunoliposomes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A61P35/04—Antineoplastic agents specific for metastasis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system

Landscapes

  • Health & Medical Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Immunology (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Dispersion Chemistry (AREA)
  • Radiology & Medical Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Oncology (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicinal Preparation (AREA)
  • Magnetic Resonance Imaging Apparatus (AREA)

Abstract

Den foreliggende oppfinnelsen beskriver et legemiddelavleveringssystem som tillater overvåking av romlig posisjon og legemiddelfrigjøring, så vel som fremgangsmåter og anvendelser derav. Mer spesielt omfatter legemiddelavleveringssystemet legemiddelbærende partikler omfattende en intern og ekstern distribusjon av magnetisk resonans avbildings kontrastmidler.The present invention discloses a drug delivery system which allows monitoring of spatial position and drug release, as well as methods and uses thereof. More particularly, the drug delivery system comprises drug-bearing particles comprising an internal and external distribution of magnetic resonance imaging contrast agents.

NO20064315A 2006-09-22 2006-09-22 T1 MRI traceable drug delivery particles and use thereof NO20064315L (en)

Priority Applications (4)

Application Number Priority Date Filing Date Title
NO20064315A NO20064315L (en) 2006-09-22 2006-09-22 T1 MRI traceable drug delivery particles and use thereof
PCT/NO2007/000334 WO2008035985A2 (en) 2006-09-22 2007-09-21 T1 mri trackable drug delivery particles, uses and methods thereof
EP07808630A EP2066357A2 (en) 2006-09-22 2007-09-21 T1 mri trackable drug delivery particles, uses and methods thereof
US12/441,116 US20100158817A1 (en) 2006-09-22 2007-09-21 T1 mri trackable drug delivery particles, uses and methods thereof

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
NO20064315A NO20064315L (en) 2006-09-22 2006-09-22 T1 MRI traceable drug delivery particles and use thereof

Publications (1)

Publication Number Publication Date
NO20064315L true NO20064315L (en) 2008-03-24

Family

ID=38805697

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20064315A NO20064315L (en) 2006-09-22 2006-09-22 T1 MRI traceable drug delivery particles and use thereof

Country Status (4)

Country Link
US (1) US20100158817A1 (en)
EP (1) EP2066357A2 (en)
NO (1) NO20064315L (en)
WO (1) WO2008035985A2 (en)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2142167A2 (en) * 2007-03-30 2010-01-13 Epitarget As Acoustically sensitive drug delivery particles
US12097269B2 (en) * 2010-10-27 2024-09-24 Vikas Kundra Dual mode gadolinium nanoparticle contrast agents
JP2014503575A (en) 2011-01-31 2014-02-13 ナノビオティックス Method for monitoring release of products of interest from liposomes using superparamagnetic nanoparticles
PL2670394T3 (en) 2011-01-31 2019-03-29 Nanobiotix Nanoparticles delivery systems, preparation and uses thereof
AU2012351537B2 (en) 2011-12-16 2017-03-02 Nanobiotix Nanoparticles comprising metallic and hafnium oxide materials, preparation and uses thereof
WO2014054026A1 (en) * 2012-10-04 2014-04-10 University Of The Witwatersrand, Johannesburg Liposomal drug delivery system
KR20150078952A (en) * 2013-12-31 2015-07-08 삼성전자주식회사 Liposome comprising active ingredient and imaging agents, and use thereof
WO2016189125A1 (en) 2015-05-28 2016-12-01 Nanobiotix Nanoparticles for use as a therapeutic vaccine

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6132764A (en) * 1994-08-05 2000-10-17 Targesome, Inc. Targeted polymerized liposome diagnostic and treatment agents
AU2003272341A1 (en) 2002-09-11 2004-04-30 Duke University Methods and compositions for blood pool identification, drug distribution quantification and drug release verification
EP2338525A3 (en) * 2003-07-09 2011-08-03 California Pacific Medical Center Remote detection of substance delivery to cells
WO2005051305A2 (en) 2003-11-19 2005-06-09 Barnes-Jewish Hospital Enhanced drug delivery
EP1732608A2 (en) * 2004-01-22 2006-12-20 Immunomedics, Inc. Folate conjugates and complexes
EP1600153A1 (en) 2004-05-26 2005-11-30 Deutsches Krebsforschungszentrum Stiftung des öffentlichen Rechts Slow-release pharmaceutical composition allowing to monitor drug release
JP2008513533A (en) 2004-09-23 2008-05-01 ゲルベ Contrast medium encapsulation system for CEST imaging
WO2007127231A2 (en) * 2006-04-24 2007-11-08 The Johns Hopkins University Magnetic resonance-detectable, ultrasound-detectable and/or radiopaque microcapsules and uses thereof

Also Published As

Publication number Publication date
US20100158817A1 (en) 2010-06-24
WO2008035985A3 (en) 2008-07-31
WO2008035985A2 (en) 2008-03-27
EP2066357A2 (en) 2009-06-10

Similar Documents

Publication Publication Date Title
NO20064315L (en) T1 MRI traceable drug delivery particles and use thereof
NL2000185A1 (en) Transportable magnetic resonance imaging (MRI) system.
ATE410186T1 (en) IN-SITU GELING DRUG DELIVERY SYSTEM
MY158019A (en) Controlled activation ingestible identifier
WO2007036952A3 (en) Novel sustained release dosage form
DE602005016148D1 (en) TARGETING AGENT FOR MOLECULAR PICTURE PRODUCTION
NL1034804A1 (en) Magnetic resonance imaging equipment and magnetic resonance imaging method.
EP2024871A4 (en) Systems and methods for managing the development and manufacturing of a drug
NL1032695A1 (en) Magnetic resonance imaging equipment and method.
FR2949062B1 (en) NEW PHARMACEUTICAL FORMULATIONS AGAINST MEASURING MEDICINES
BRPI0716196A2 (en) Drug delivery systems comprising solid solutions of weakly basic drugs.
IS7930A (en) Modified release rate of bupropion hydrochloride
JP2008539179A5 (en) Combination of insecticidal active substance combination
DE602007006324D1 (en) INSECTICIDES N-SUBSTITUTED (HETEROARYL) CYCLOALKYLSULFOXIMINE
HK1145087A1 (en) Diagnostic agent
NO20082837L (en) Isotope-labeled benzothiazole compounds as imaging agents for amyloidogenic proteins
UY30460A1 (en) THERAPEUTIC COMPOUNDS
DE602005026573D1 (en) MEASURABLE DELIVERY SYSTEM FOR INTRALUMINARY MEDICAL DEVICES
Bottenberg et al. Metronidazole-induced encephalopathy: a case report and review of the literature
WO2008033031A3 (en) Mri trackable drug delivery particles, uses and methods thereof
EA201001857A1 (en) PHARMACEUTICAL MEDICINE FORM FOR IMMEDIATE RELEASE OF INDOLINON DERIVATIVE
BRPI0818607A2 (en) Methods for disseminating information and for communicating information regarding physical attributes of patients.
MY163383A (en) Degradable removable implant for the sustained release of an active compound
EP2127677A4 (en) Aminoalkylmethacrylate copolymer e for maintaining solubility of poorly water-soluble drug
WO2007009691A3 (en) Combination of substituted pyrazolines and anti -addictive agent

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application